Review medications and compounds listed on DrugStatusIndex.com that are categorized as FDA approved for at least one recognized use, prescription category, or commercial indication.
Semaglutide injection commonly searched for diabetes management and weight-related use.
Semaglutide therapy indicated for chronic weight management.
Tirzepatide therapy with strong search demand and approval-status confusion.
Tirzepatide-based medication searched often for weight management approval status.
Oral semaglutide medication commonly searched alongside GLP-1 therapies.
Liraglutide therapy searched for weight-management approval information.
Dulaglutide GLP-1 therapy commonly searched for prescription and approval status.
Liraglutide medication searched for GLP-1 and FDA approval details.
Exenatide therapy included in the DrugStatusIndex approval directory.
Exenatide extended-release therapy listed in the approved drug section.
Weight-management medication listed in the FDA approved category.
Prescription weight-management medication included in the approved directory.
Orlistat prescription medication searched for weight-loss approval status.
Over-the-counter orlistat product included in the approved drug index.
Setmelanotide therapy listed for rare obesity-related indications.
Each medication may have different approved indications, forms, strengths, and prescription requirements.
Some drugs are searched by brand name while FDA records may reference the generic ingredient.
A drug may be approved for one purpose while being searched for another use or category.